Monitor Quote Charts Trades News Financials Toplists Alerts Portfolio Level 2 Message Boards
  17/05/2008
10:07:58
Site map		   Help
 
 
 
Abraxis Bioscience (MM)
   
To register click here

Abraxis Bioscience Stock Price ABBI

Abraxis Bioscience stock quote | Abraxis Bioscience company information | Abraxis Bioscience Stock Chart | Abraxis Bioscience Stock News
Name:
Abraxis Bioscience (MM)		 Symbol:
NASDAQ:ABBI		 Stock Market:
NASDAQ Stock Market		 Type:
Common Stock		 ISIN:
 Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
To register Click hereRegister for free Abraxis Bioscience stock prices.

APP Pharmaceuticals rated 'BB' with stable outlook - S&P : MUMBAI (Thomson Financial) - Standard & Poor's Ratings Services assigned its 'BB' corporate credit rating with stable outlook to APP Pharmaceuticals Inc, the injectable generic drug business of Abraxis Bioscience which...

Free Abraxis Bioscience Stock Charts

Abraxis Bioscience Historical Stock Chart
Abraxis Bioscience Historical Stock Chart
Abraxis Bioscience Monthly Stock Chart
Abraxis Bioscience Monthly Stock Chart		Abraxis Bioscience Intraday stock chart
Abraxis Bioscience Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Abraxis Bioscience stock Price, quotes, trades and FREE Abraxis Bioscience stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Abraxis Bioscience (ABBI) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Abraxis Bioscience News

Latest Abraxis Bioscience News Headlines
DateTimeSource
Headline
11/08/200711:07PMTFNFAPP Pharmaceuticals rated 'BB' with stable outlook - S&P
11/08/20077:55AMTFNFAPP Pharmaceuticals' unit rated 'Ba3' with stable outlook - Moody's
10/18/20073:56AMTFNFBiocon gets regulatory ok to sell breast cancer drug in India; H1 net up UPDATE
10/17/20073:41AMTFNFAbraxis BioScience gets US FDA approval for generic version of Bayer's Fludara
10/05/20078:50AMTFNFAbraxis gets generic Camptosar approval
09/11/20078:19AMTFNFAbraxis gets tentative generic Kytril OK
07/19/20077:42AMTFNFBiocon signs licensing agreement with US-based Abraxis BioScience
07/02/20077:30AMTFNFAbraxis BioScience to separate into two companies
06/04/20078:33PMPRNUSNew Data Shows Promising Antitumor Activity with nab-paclitaxel (ABRAXANE(R)) in Combination and as a Single Agent for the Treat

Abraxis Bioscience Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Abraxis Bioscience company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Abraxis Bioscience Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
      USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
30 site:2us nasdaq abbi080517 10:07 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )